INTRAVESICAL BACILLUS CALMETTE-GUERIN FOR NONMUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER - PATTERNS OF USE, AND IMPACT ON OUTCOMES

被引：0
|
作者：
Azer, S. [1 ]
Ranasinghe, W. [2 ]
Webb, C. [1 ]
Lioufas, P. A. [2 ]
Cetti, R. [2 ]
Frydenberg, M. [2 ,3 ]
Bolton, D. [1 ,4 ]
Appu, S. [2 ,3 ]
Sengupta, S. [1 ,4 ]
机构：
[1] Austin Hlth, Dept Urol, Melbourne, Vic, Australia
[2] Monash Med Ctr, Dept Urol, Melbourne, Vic, Australia
[3] Monash Univ, Dept Surg, Melbourne, Vic 3004, Australia
[4] Univ Melbourne, Austin Dept Surg, Melbourne, Vic, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 11卷
关键词：
Bacillus Calmette-Guerin; urothelial carcinoma; nonmuscle invasive bladder cancer; prognostic factors;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
119
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [1] Intravesical Bacillus Calmette-Guerin for non-muscle invasive urothelial carcinoma of the bladder - patterns of use, and impact on outcomes
    Azer, S.
    Ranasinghe, W.
    Gibson, L.
    Webb, C.
    Lioufas, P. A.
    Cetti, R.
    Frydenberg, M.
    Bolton, D.
    Appu, S.
    Sengupta, S.
    [J]. BJU INTERNATIONAL, 2015, 115 : 3 - 3
  • [2] Outcomes of Intravesical bacillus Calmette-Guerin in a Multiracial Cohort with Nonmuscle Invasive Bladder Cancer
    Barry, Emily
    Agalliu, Ilir
    Maiman, Richard
    Shreck, Evan
    Kovac, Evan
    Aboumohamed, Ahmed
    Sankin, Alexander
    [J]. UROLOGY PRACTICE, 2021, 8 (01) : 100 - 105
  • [3] INTRAVESICAL BACILLUS CALMETTE - GUERIN: PATTERNS OF USE AND OUTCOMES FOR NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Huang, Dora
    Khan, Munad
    Azer, Sarah
    Sengupta, Shomik
    Lawrentschuk, Nathan
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 48 - 48
  • [4] Impact of smoking on outcomes after intravesical bacillus Calmette-Guerin therapy for urothelial carcinoma not invading muscle of the bladder
    Sfakianos, John P.
    Shariat, Shahrokh F.
    Favaretto, Ricardo Lima
    Rioja, Jorge
    Herr, Harry W.
    [J]. BJU INTERNATIONAL, 2011, 108 (04) : 526 - 530
  • [5] INTRAVESICAL BACILLUS CALMETTE-GUERIN GLOBAL SHORTAGE: IMPACT ON THE MANAGEMENT OF NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER
    Huang, Dora
    Khan, Munad
    Sengupta, Shomik
    Lawrentschuk, Nathan
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 : 47 - 47
  • [6] Utilization of Bacillus Calmette-Guerin for Nonmuscle Invasive Bladder Cancer in an Era of Bacillus Calmette-Guerin Supply Shortages
    Khanna, Abhinav
    Yerram, Nitin
    Zhu, Hui
    Kim, Simon
    Abouassaly, Robert
    [J]. UROLOGY, 2019, 124 : 120 - 125
  • [7] Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder
    Kresowik, Timothy P.
    Griffith, Thomas S.
    [J]. IMMUNOTHERAPY, 2009, 1 (02) : 281 - 288
  • [8] The impact on survival outcomes of different Bacillus Calmette-Guerin strains of nonmuscle invasive bladder cancer patients
    Liu, K.
    Zhao, H.
    Chen, X.
    Chiu, P. K.
    Ng, C.
    Teoh, J. Y.
    [J]. EUROPEAN UROLOGY, 2023, 83 : S396 - S396
  • [9] Intravesical Immunomodulatory Imiquimod Enhances Bacillus Calmette-Guerin Downregulation of Nonmuscle-invasive Bladder Cancer
    Camargo, Juliana A.
    Passos, Gabriela R.
    Ferrari, Karen L.
    Billis, Athanase
    Saad, Mario J. A.
    Reis, Leonardo O.
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (03) : E587 - E593
  • [10] A Phase 2 Trial of Intravesical Gemcitabine and Docetaxel in the Treatment of Bacillus Calmette-Guerin?Naive Nonmuscle-Invasive Urothelial Carcinoma of the Bladder EDITORIAL COMMENT
    Bharadwaj, Maheetha
    Koehne, Elizabeth L.
    [J]. JOURNAL OF UROLOGY, 2024, 212 (01): : 103 - 103
12345